Little-known medical device firm Allurion (NYSE:ALUR) — which is focused on ending obesity via its swallowable and “procedure-less” intragastric balloon — saw its shares skyrocket on Thursday. Earlier this morning, management announced the commercial availability of its comprehensive Virtual Care Suite (VCS) in the U.S. ALUR stock likely benefited from rising interest in anti-obesity treatments.According to the company’s press release, the VCS is a dynamic weight-loss management suite powered by artificial ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities registered pursuant to Section 12(b) of the Act: FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41767 Allurion Technologies, Inc. (Exact name of registrant as specified ...

Allurion Technologies Inc. (NYSE:ALUR) Q4 2023 Results Earnings Conference Call March 21, 2024 8:30 AM ET Company Participants Michael Cavanaugh - Investor Relations, ICR Westwicke Shantanu Gaur - Chief Executive Officer Chris Geberth - Chief Financial Officer Conference Call Participants Matthew Taylor - Jefferies Ryan Zimmerman - BTIG Keay Nakae - Chardan Capital Markets Michael Cavanaugh Good morning. Thank you all for joining us today. Earlier today, Allurion Technologies Incorporated issued a press rel ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the BTIG Snowbird Conference taking place on Monday, February 12 through Wednesday, February 14, 2024 in Snowbird. Shantanu Gaur, Allurion’s Chief Executive Officer, and Chris Geberth, Chief Financial Officer, will be available for investor 1x1 meetings. About Allurion Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Brendan Gibbons as its new Chief Legal Officer and corporate secretary. Brendan joins Allurion with nearly 20 years’ experience as a chief legal and compliance officer at three separate public companies. Most recently, Brendan served as Executive Vice President and Chief Legal Officer at Acushnet Company, the parent company of Titleist and other golf brands an ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that the Somerset NHS Foundation Trust (FT) is the first NHS trust in the United Kingdom, and the first non-private sector organisation in the world, to introduce the Allurion Gastric Balloon - the world's only swallowable gastric balloon that requires no surgery, no endoscopy and no anaesthesia1. Once swallowed, the balloon is filled and remains in the stomach for approximately 4 ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced further expansion of its Virtual Care Suite (VCS) digital platform with new commercial agreements signed with Lazeo, France's largest aesthetic and weight loss clinic chain, and Transform, UK's largest aesthetic and weight loss clinic chain. After recently expanding its commercial agreement with Weight Doctors®—Germany’s leading group of private clinics and centers for weight loss ...

Allurion Technologies Inc. (NYSE:ALUR) Q3 2023 Results Conference Call November 13, 2023 8:30 AM ET Company Participants Mike Cavanaugh - ICR of Westwicke Shantanu Gaur - Founder and Chief Executive Officer Chris Geberth - Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Ross Osborn - Cantor Fitzgerald Ryan Zimmerman - BTIG Chris Pasquale - Nephron Research Operator Hello, and welcome to the Allurion Third Quarter Earnings Call. All lines have been placed on mute to prevent any ...

WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to _________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number: 001-41767 Allurion Technologies, Inc. (Exact Name of Registrant as Specified in its Charter) ...

Exhibit 99.1 Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update Completed NYSE listing and business combination generating $92M in net proceeds Generated 40% sequential revenue growth in first quarter as a public company Completed enrollment in AUDACITY FDA pivotal trial for Allurion Balloon Launched Coach Iris, a conversational, 24/7, and generative AI-powered weight loss coach Natick, MA – November 13, 2023 – Allurion Technologies, Inc. (NYSE: ALUR) ("Allurion"), a company ...